Results 311 to 320 of about 881,201 (350)
Some of the next articles are maybe not open access.
Coronary Artery Disease, 2023
Background There is a lack of current research examining the predictive value of the Intermountain Risk Score (IMRS) in patients with ST-segment elevation myocardial infarction (STEMI) caused by cardiogenic shock.
Hayıroğlu Mert İlker +4 more
semanticscholar +1 more source
Background There is a lack of current research examining the predictive value of the Intermountain Risk Score (IMRS) in patients with ST-segment elevation myocardial infarction (STEMI) caused by cardiogenic shock.
Hayıroğlu Mert İlker +4 more
semanticscholar +1 more source
Advances in the Management of Cardiogenic Shock
Critical Care Medicine, 2023OBJECTIVES: To review a contemporary approach to the management of patients with cardiogenic shock (CS). DATA SOURCES: We reviewed salient medical literature regarding CS.
J. Jentzer +5 more
semanticscholar +1 more source
Current Treatment Options in Cardiovascular Medicine, 2000
In the setting of acute myocardial infarction, the timely recognition and treatment of cardiogenic shock are essential in reducing the incidence of death. Patients with cardiogenic shock should be treated aggressively with a combination of pharmacologic agents and mechanical support devices to achieve stabilization. Once stabilization has been achieved,
Richard W. Smalling, Michael Rihner
openaire +3 more sources
In the setting of acute myocardial infarction, the timely recognition and treatment of cardiogenic shock are essential in reducing the incidence of death. Patients with cardiogenic shock should be treated aggressively with a combination of pharmacologic agents and mechanical support devices to achieve stabilization. Once stabilization has been achieved,
Richard W. Smalling, Michael Rihner
openaire +3 more sources
Cardiology Clinics, 1995
Despite advancements in the pharmacologic treatment of acute myocardial infarction and the introduction of mechanical hemodynamic support, in-hospital mortality rates for cardiogenic shock have remained between 70% and 80%. In addition, the proven beneficial effects of thrombolytic therapy in reducing mortality in acute myocardial infarction have not ...
M, Moscucci, E R, Bates
openaire +2 more sources
Despite advancements in the pharmacologic treatment of acute myocardial infarction and the introduction of mechanical hemodynamic support, in-hospital mortality rates for cardiogenic shock have remained between 70% and 80%. In addition, the proven beneficial effects of thrombolytic therapy in reducing mortality in acute myocardial infarction have not ...
M, Moscucci, E R, Bates
openaire +2 more sources
Emergency Medicine Clinics of North America, 2015
Cardiogenic shock is the leading cause of morbidity and mortality in patients presenting with acute coronary syndrome. Although early reperfusion strategies are essential to the management of these critically ill patients, additional treatment plans are often needed to stabilize and treat the patient before reperfusion may be possible.
Joshua B, Moskovitz +2 more
openaire +4 more sources
Cardiogenic shock is the leading cause of morbidity and mortality in patients presenting with acute coronary syndrome. Although early reperfusion strategies are essential to the management of these critically ill patients, additional treatment plans are often needed to stabilize and treat the patient before reperfusion may be possible.
Joshua B, Moskovitz +2 more
openaire +4 more sources
Hospital Practice, 2010
The syndrome of cardiogenic shock (CS) comprises a constellation of symptoms and signs that define a subset of patients with inadequate tissue perfusion secondary to myocardial dysfunction. Careful attention to and rapid identification of patients at risk for the development of CS and those with impending CS by both hospitalists and subspecialists will
Nitasha, Sarswat, Steven M, Hollenberg
openaire +5 more sources
The syndrome of cardiogenic shock (CS) comprises a constellation of symptoms and signs that define a subset of patients with inadequate tissue perfusion secondary to myocardial dysfunction. Careful attention to and rapid identification of patients at risk for the development of CS and those with impending CS by both hospitalists and subspecialists will
Nitasha, Sarswat, Steven M, Hollenberg
openaire +5 more sources
Dimensions of Critical Care Nursing, 2008
Despite advances in treatment, the mortality rate of patients who develop cardiogenic shock after an acute myocardial infarction remains unacceptably high. This article presents an overview of cardiogenic shock--incidence, epidemiology, predisposing factors, pathophysiology, and management, both medical and surgical.
Simon, Topalian +2 more
openaire +4 more sources
Despite advances in treatment, the mortality rate of patients who develop cardiogenic shock after an acute myocardial infarction remains unacceptably high. This article presents an overview of cardiogenic shock--incidence, epidemiology, predisposing factors, pathophysiology, and management, both medical and surgical.
Simon, Topalian +2 more
openaire +4 more sources
Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock
European Journal of Heart Failure, 2022Cardiogenic shock (CS) with variable systemic inflammation may be responsible for patient heterogeneity and the exceedingly high mortality rate. Cardiovascular events have been associated with clonal haematopoiesis (CH) where specific gene mutations in ...
F. Scolari +14 more
semanticscholar +1 more source
Cardiology Clinics, 2018
Cardiogenic shock (CS) is a physiologic state in which cardiac pump function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated, tissue hypoperfusion can quickly lead to organ dysfunction and patient death. Evaluation of patients with suspected CS should include an electrocardiogram, chest radiograph, laboratory studies ...
Semhar Z, Tewelde +2 more
openaire +2 more sources
Cardiogenic shock (CS) is a physiologic state in which cardiac pump function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated, tissue hypoperfusion can quickly lead to organ dysfunction and patient death. Evaluation of patients with suspected CS should include an electrocardiogram, chest radiograph, laboratory studies ...
Semhar Z, Tewelde +2 more
openaire +2 more sources
Critical Care Clinics, 2001
Mortality rates in patients with cardiogenic shock remain frustratingly high. Its pathophysiology involves a downward spiral in which ischemia causes myocardial dysfunction, which in turn worsens ischemia. Areas of viable but nonfunctional myocardium can contribute to the development of cardiogenic shock.
openaire +3 more sources
Mortality rates in patients with cardiogenic shock remain frustratingly high. Its pathophysiology involves a downward spiral in which ischemia causes myocardial dysfunction, which in turn worsens ischemia. Areas of viable but nonfunctional myocardium can contribute to the development of cardiogenic shock.
openaire +3 more sources